OptiNose (OPTN) Stock Chart & Stock Price History → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free OPTN Stock Alerts $1.08 +0.01 (+0.93%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends OptiNose Stock Price Performance5 Day Performance-7.69%1 Month Performance+23.06%3 Month Performance-43.46%6 Month Performance-14.29%Year-To-Date Performance-16.28%1 Year Performance-10.74% Receive OPTN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. OPTN Stock Chart for Sunday, June, 2, 2024 OPTN Chart by TradingView OptiNose Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.07$1.08+0.93%$1.10$1.03490,601 shs$122.08 million05/30/2024$1.07$1.07$1.10$1.06425,794 shs$120.95 million05/29/2024$1.17$1.07-8.55%$1.16$1.06720,225 shs$120.95 million05/28/2024$1.11$1.17+5.41%$1.20$1.10602,383 shs$132.26 million05/27/2024$1.11$1.11$1.15$1.09647,200 shs$125.47 million05/24/2024$1.13$1.11-1.77%$1.15$1.09647,267 shs$125.47 million Get the Latest News and Ratings for OPTN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.16$1.13-2.59%$1.16$1.10544,060 shs$127.74 million05/22/2024$1.16$1.16$1.18$1.13330,918 shs$131.13 million05/21/2024$1.20$1.16-3.33%$1.23$1.12577,311 shs$131.13 million05/20/2024$1.26$1.20-4.76%$1.33$1.181.11 million shs$135.65 million05/17/2024$1.29$1.26-2.33%$1.33$1.22899,255 shs$142.43 million05/16/2024$1.19$1.29+8.86%$1.31$1.16754,231 shs$145.82 million05/15/2024$1.13$1.19+4.87%$1.19$1.11568,954 shs$133.95 million05/14/2024$1.17$1.13-3.42%$1.17$1.05976,931 shs$127.73 million05/13/2024$1.22$1.17-4.10%$1.25$1.15659,322 shs$132.26 million05/10/2024$1.12$1.22+8.93%$1.24$1.12842,450 shs$137.91 million05/09/2024$1.04$1.12+7.69%$1.18$1.001.57 million shs$126.60 million05/08/2024$1.03$1.04+0.97%$1.04$1.01220,015 shs$117.56 million05/07/2024$1.14$1.03-9.65%$1.15$1.01851,775 shs$116.43 million05/06/2024$1.01$1.14+12.87%$1.21$1.072.79 million shs$128.87 million05/03/2024$0.88$1.01+15.09%$1.01$0.881.10 million shs$114.17 million05/02/2024$0.91$0.88-3.37%$0.93$0.87514,378 shs$99.20 million05/01/2024$0.82$0.91+10.62%$0.92$0.82815,060 shs$102.66 million04/30/2024$0.86$0.82-4.45%$0.85$0.811.21 million shs$92.49 million04/29/2024$0.86$0.86-0.14%$0.88$0.831.37 million shs$96.79 million04/26/2024$0.91$0.86-4.93%$0.91$0.803.14 million shs$96.92 million04/25/2024$0.93$0.91-2.19%$1.25$0.8923.36 million shs$101.95 million04/24/2024$0.97$0.93-4.38%$0.96$0.89571,324 shs$104.24 million04/23/2024$1.03$0.97-6.05%$1.06$0.94671,563 shs$109.01 million04/22/2024$0.89$1.03+15.19%$1.05$0.861.26 million shs$116.03 million04/19/2024$0.93$0.89-3.61%$0.97$0.89653,099 shs$100.73 million04/18/2024$1.02$0.93-9.05%$1.03$0.92548,193 shs$104.51 million04/17/2024$1.09$1.02-6.42%$1.13$1.01461,327 shs$114.90 million04/16/2024$1.19$1.09-8.40%$1.19$1.09362,600 shs$122.79 million04/15/2024$1.22$1.19-2.46%$1.22$1.16508,955 shs$134.06 million04/12/2024$1.24$1.22-1.61%$1.25$1.16796,543 shs$137.43 million04/11/2024$1.25$1.24-0.80%$1.26$1.22615,835 shs$139.69 million04/10/2024$1.23$1.25+1.63%$1.25$1.20439,385 shs$140.82 million04/09/2024$1.33$1.23-7.52%$1.36$1.22350,815 shs$138.56 million04/08/2024$1.32$1.33+0.76%$1.35$1.30284,915 shs$149.82 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$1.37$1.32-3.65%$1.41$1.30377,720 shs$148.70 million04/04/2024$1.38$1.37-0.72%$1.40$1.34438,945 shs$154.33 million04/03/2024$1.41$1.38-2.13%$1.43$1.38233,597 shs$155.46 million04/02/2024$1.44$1.41-2.08%$1.47$1.40187,855 shs$158.84 million04/01/2024$1.46$1.44-1.37%$1.49$1.42492,460 shs$162.22 million03/29/2024$1.46$1.46$1.50$1.41399,834 shs$164.47 million03/28/2024$1.48$1.46-1.35%$1.50$1.41399,574 shs$164.47 million03/27/2024$1.48$1.48$1.49$1.43400,436 shs$166.72 million03/26/2024$1.50$1.48-1.33%$1.56$1.46443,253 shs$166.72 million03/25/2024$1.63$1.50-7.98%$1.64$1.46995,181 shs$168.98 million03/22/2024$1.66$1.63-1.81%$1.68$1.57770,338 shs$183.62 million03/21/2024$1.72$1.66-3.21%$1.72$1.62431,559 shs$187.00 million03/20/2024$1.72$1.72-0.29%$1.76$1.621.55 million shs$193.20 million03/19/2024$1.94$1.72-11.11%$1.98$1.691.49 million shs$193.76 million03/18/2024$1.88$1.94+2.93%$2.10$1.764.25 million shs$217.98 million03/15/2024$1.90$1.87-1.58%$1.93$1.724.35 million shs$210.66 million03/14/2024$1.93$1.90-1.55%$1.92$1.85349,553 shs$214.04 million03/13/2024$1.90$1.93+1.85%$1.94$1.85504,346 shs$217.41 million03/12/2024$1.86$1.90+1.88%$1.91$1.83363,152 shs$213.47 million03/11/2024$1.68$1.86+10.71%$1.89$1.70797,249 shs$208.90 million03/08/2024$1.72$1.68-2.33%$1.77$1.64452,941 shs$188.68 million03/07/2024$1.75$1.72-1.71%$1.78$1.62384,834 shs$193.17 million03/06/2024$1.73$1.75+1.45%$1.79$1.72310,082 shs$196.54 million03/05/2024$1.73$1.73-0.29%$1.77$1.66316,748 shs$193.74 million03/04/2024$1.91$1.73-9.42%$1.94$1.67653,931 shs$194.30 million03/01/2024$1.78$1.91+7.30%$1.91$1.77471,365 shs$214.51 million Related Companies: scPharmaceuticals Stock Price Chart Veru Stock Price Chart Aquestive Therapeutics Stock Price Chart Neurogene Stock Price Chart Fulcrum Therapeutics Stock Price Chart Mereo BioPharma Group Stock Price Chart Oculis Stock Price Chart Korro Bio Stock Price Chart AC Immune Stock Price Chart Corbus Pharmaceuticals Stock Price Chart Receive OPTN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OptiNose and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OPTN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiNose, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.